Sherbrooke Park Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
+28,893
| New | +$1.34M | 0.58% | 13 |
|
|
2024
Q3 | – | Sell |
-13,678
| Closed | -$568K | – | 931 |
|
|
2024
Q2 | $568K | Buy |
13,678
+5,867
| +75% | +$244K | 0.1% | 360 |
|
|
2024
Q1 | $424K | Sell |
7,811
-5,093
| -39% | -$276K | 0.08% | 428 |
|
|
2023
Q4 | $662K | Sell |
12,904
-26,034
| -67% | -$1.34M | 0.31% | 111 |
|
|
2023
Q3 | $2.26M | Buy |
38,938
+21,638
| +125% | +$1.26M | 0.72% | 9 |
|
|
2023
Q2 | $1.11M | Buy |
17,300
+12,400
| +253% | +$793K | 0.58% | 29 |
|
|
2023
Q1 | $340K | Sell |
4,900
-11,000
| -69% | -$762K | 0.51% | 81 |
|
|
2022
Q4 | $1.14M | Buy |
+15,900
| New | +$1.14M | 0.84% | 14 |
|